Grafa News and Videos — Page 9

Aquirian (ASX:AQN) completed its planned Wubin facility upgrades on budget during the first quarter of FY27.

AFT Pharmaceuticals (ASX:AFP) announced sustained double-digit revenue growth for the first half of FY27.

New Zealand insurer Tower (ASX:TWR) raised its full-year underlying net profit forecast to between NZ$69 million and NZ$79 million.

Mader Group (ASX:MAD) has distributed $51.8 million worth of shares to staff after meeting its 2026 profit goals.

Australia and Japan signed a five-year memorandum of cooperation to hold annual talks on financial policy and economic security issues.

The Coalition leadership group approved a migration policy setting Australia's eventual net overseas migration target at 160,000 arrivals per year.

Taiwan Semiconductor Manufacturing Company (NYSE:TSM) reached an intraday stock high following confirmed factory partnership discussions.

Qualcomm (NASDAQ:QCOM) initiated a federal trial in Delaware to freeze royalty payments to Arm Holdings (NASDAQ:ARM) for up to five years over alleged contract breaches.

Crescent Biopharma (NASDAQ:CBIO) received FDA clearance for its Investigational New Drug application for CR-002, an antibody-drug conjugate being developed for advanced solid tumors.

Alterity Therapeutics (NASDAQ:ATHE) reported additional Phase 2 analyses showing ATH434 50 mg slowed functional decline in multiple system atrophy by approximately 52% compared with placebo at Week 52.